John Nielsen - Cardiovascular Systems VP Communications
Insider
John Nielsen is VP Communications of Cardiovascular Systems
| Phone | 651 259 1600 |
| Web | https://www.csi360.com |
Cardiovascular Systems Management Efficiency
The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities.Cardiovascular Systems currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cardiovascular Systems' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| John Liu | Sight Sciences | N/A | |
| Meghan Scanlon | Paragon 28 | 48 | |
| Donald Middlebrook | Nevro Corp | 69 | |
| Shanna Cottiosmanski | CONMED | 48 | |
| Thomas Timbie | Treace Medical Concepts | 66 | |
| Rajbir Denhoy | Establishment Labs Holdings | 54 | |
| Karen Prange | Nevro Corp | 56 | |
| Collin DSilva | Bruker | 67 | |
| Laura MBA | Si Bone | 58 | |
| Martha Morrell | Neuropace | 67 | |
| Marco Dolci | LivaNova PLC | 62 | |
| Michael Favet | Neuropace | 54 | |
| McAlister Marshall | Integer Holdings Corp | 51 | |
| James Lovgren | MaxCyte | N/A | |
| David Haffner | Glaukos Corp | N/A | |
| Sam Park | Sight Sciences | 63 | |
| B Johnson | Paragon 28 | 68 | |
| Laverne Council | CONMED | 59 | |
| Lee Rosenthal | Paragon 28 | N/A | |
| Martin Vazquez | Outset Medical | 53 | |
| Stark Thompson | MaxCyte | 83 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 |
Cardiovascular Systems Leadership Team
Elected by the shareholders, the Cardiovascular Systems' board of directors comprises two types of representatives: Cardiovascular Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiovascular. The board's role is to monitor Cardiovascular Systems' management team and ensure that shareholders' interests are well served. Cardiovascular Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiovascular Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philip Freed, VP Marketing | ||
| Stephen Rempe, Chief Officer | ||
| Jeffrey MD, Chief Officer | ||
| Peter Hirshman, VP Operations | ||
| Sandra Sedo, Chief Compliance Officer | ||
| Jeffrey Points, Chief Officer | ||
| BSc MS, Pres Chairman | ||
| Alexander Rosenstein, General Counsel and Corporate Secretary | ||
| John Nielsen, VP Communications |
Cardiovascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardiovascular Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Transaction History View history of all your transactions and understand their impact on performance |